News / Press Releases
Important Update to Shareholders: Share Consolidation Clarification
NanaBisTM - Now With Synthetic CBD and THC
Medlab proposes DUAL LISTING to the U.S. Nasdaq Stock Market
Presentations
Jane King interviews Sean Hall, M.D., CEO, Medlab
Medlab signs exclusive commercial agreement for 12 products with YesHealth
Dr Sean Hall interviewed by Ari Zoldan
About
NanoCelle®
Science
Our products
Investors & media
Partnering with us
Patients & HCPs
Find a Prescriber
CORPORATE OFFICES
11-13 LORD ST, BOTANY
BUILDING A, UNIT A5 – A6, BOTANY QUARTER
NSW, 2019, AUSTRALIA
11-13 LORD ST, BOTANY
BUILDING A, UNIT A5 – A6, BOTANY QUARTER
NSW, 2019, AUSTRALIA
Regional and International offices
OUR WEBSITES
www.medlab.co
www.medlab.co
CONTACT DETAILS
OFFICE HOURS: 8:30AM - 5PM EST
AUS: 1300 369 570
AUS: +61 2 8188 0311
USA: +1 947 771 8119
UK: +44 20 8138 0311
FAX: +61 2 9699 3347
Email: [email protected]
OFFICE HOURS: 8:30AM - 5PM EST
AUS: 1300 369 570
AUS: +61 2 8188 0311
USA: +1 947 771 8119
UK: +44 20 8138 0311
FAX: +61 2 9699 3347
Email: [email protected]